Evolution’s €2 Billion Buyback Signals Confidence in Americas Growth Despite New Jersey Litigation Risks

Evolution AB announced a €2 billion share buyback programme on Tuesday. The supplier also secured a €300 million revolving credit facility to maintain liquidity through the repurchases. The move comes after the company reported that North and Latin America now drive its growth while 48% of Q1 revenue came from regulated jurisdictions.

After eighteen years on bookmaker trading floors I have seen plenty of capital returns. This one stands out. Evolution is committing serious cash at a moment when its US legal exposure remains unresolved. The data says the Americas matter more than ever. The risk section says the path there is not clean.

Capital Return Meets Regulatory Pressure

The board authorised repurchases of shares worth up to €2 billion on Nasdaq Stockholm or other regulated markets. An independent investment firm or credit institution will handle timing and execution. The programme can run until the full amount is used or until further notice, potentially through the 2027 annual general meeting.

Shares will be paid for in cash within price limits set by market conditions. Swedish rules cap any holding at 10% of issued shares. With 199,226,613 shares outstanding and zero treasury shares the maximum repurchase stands at 19,922,661 shares. The board flagged the possibility of an extraordinary general meeting to cancel shares and refresh authorisation if the limit is approached.

This follows shareholder approval at the Annual General Meeting on 24 April. The stated purpose was to optimise the capital structure by reducing share capital and creating added shareholder value.

The buyback arrives while Evolution faces increased regulatory and legal scrutiny. The company remains in ongoing legal proceedings in New Jersey over allegations that its games reached unauthorised operators in restricted markets. Evolution has repeatedly denied the claims.

Americas Pivot Backed by Regulated Revenue Share

Evolution has been re-evaluating its focus. Its Q1 earnings showed growth driven largely by North and Latin America rather than Europe. According to the company 48% of its Q1 revenue was generated from regulated jurisdictions.

The numbers line up with an operator-first view of market making. When nearly half your revenue clears regulatory hurdles the incentive to double down on compliant jurisdictions is obvious. The buyback looks like a vote of confidence in that shift. It also looks like a hedge against slower European momentum.

From the trading floor perspective this is straightforward capital allocation. Return excess cash when growth vectors are clear. The €2 billion programme and the €300 million facility together signal that Evolution wants flexibility without starving the balance sheet.

New Jersey Litigation and North American Market Access

The capital management plans land amid active disputes. Evolution sought to add Playtech to a defamation lawsuit tied to the long-running New Jersey matter. The supplier alleges Playtech orchestrated and funded a false and commercially motivated smear campaign to damage its reputation and obstruct entry into the North American online gaming market.

Playtech allegedly engaged Black Cube to investigate Evolution’s activities in prohibited and unlicensed markets. Playtech has stated that the investigation had been undertaken lawfully. The Superior Court of New Jersey will decide whether the amended complaint can proceed.

Evolution is also being investigated by the UK Gambling Commission for links between its games and unlicensed sites. The outcome of that multi-year review remains pending.

These cases matter because North American access is now central to the growth story. A supplier generating 48% regulated revenue cannot treat US legal risk as background noise. Any restriction or prolonged uncertainty directly hits the pivot that justifies the buyback size.

Liquidity Facility and Risk of Prolonged Legal Drag

In parallel Evolution established a €300 million senior unsecured revolving credit facility with JP Morgan SE and Citibank Europe plc. The facility carries a three-year bullet repayment schedule with two optional one-year extensions. It serves as standby financing to preserve financial flexibility.

The company described the buyback as a material adjustment to its capital structure. Securing the facility at the same time reads as prudent risk management. Liquidity matters when legal proceedings could stretch for months or years and when share repurchases must stay within regulatory caps.

The counterargument is clear. A €2 billion programme is aggressive if litigation outcomes worsen or if regulated revenue growth slows. Holding up to 10% of shares in treasury before cancellation adds another layer of execution risk. Should the New Jersey court allow the amended complaint or the UK review produce restrictions the market may question the timing.

Still the data on the table shows the Americas contribution rising. The buyback and facility together suggest Evolution believes its regulatory exposure is manageable. The next twelve months will test whether that belief holds when the cash actually leaves the balance sheet.

The Bottom Line

Evolution is putting €2 billion behind its Americas-led growth at the same time its New Jersey litigation and UK Gambling Commission investigation continue. The 48% regulated revenue figure from Q1 anchors the strategic bet. Execution through an independent firm and the €300 million standby facility show operational discipline. The real test will be whether legal resolution in North America keeps pace with the capital return. If it does the buyback strengthens the supplier’s position heading into a critical US market cycle. If not the programme may prove expensive insurance against prolonged uncertainty.